Calcium Channel Blockers/adverse effects

Rouette, J., McDonald, E. G., Schuster, T., Brophy, J. M., & Azoulay, L. (2022). Dihydropyridine Calcium Channel Blockers and Risk of Pancreatic Cancer: A Population-Based Cohort Study. J Am Heart Assoc, 11, e026789. http://doi.org/10.1161/jaha.122.026789